Predictive Presymptomatic Testing Market - 40% of Growth to Originate from North America|Evolving Opportunities with 23andMe Inc. & Abbott Laboratories |Technavio

NEW YORK, April 18, 2022 /PRNewswire/ -- The Predictive Presymptomatic Testing Market report provides a detailed analysis on the competitive scenario, drivers, trends, challenges, and market growth across various regions. The predictive presymptomatic testing market value is set to grow by USD 2.45 billion from 2021 to 2026 progressing at a CAGR of 9.6% from 2021 to 2026. 40% of the market's growth will originate from North America during the forecast period. The US is the key market for the predictive presymptomatic testing market in North America. Market growth in this region will be slower than the growth of the market in Asia. The increasing prevalence of multiple types of cancer will facilitate the predictive presymptomatic testing market growth in North America over the forecast period.

For more insights on the market share of various regions - Download a free sample now!

Market Dynamics

The market is driven by factors such as the increasing healthcare spending worldwide, increasing demand for genetic counseling, and the rise in awareness toward early screening of genetic disorders. However, the high cost of tests is hindering market growth. The holistic analysis of the drivers & challenges will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Company Profiles

 The predictive presymptomatic testing market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market. The predictive presymptomatic testing market report includes information on the product launches, sustainability, and prospects of leading vendors including 23andMe Inc., Abbott Laboratories, Amgen Inc., BioAxis DNA Research Centre P Ltd., Color Genomics Inc., Deep Genomics, Direct Laboratory Services LLC, DNA and U, Editas Medicine Inc., Healius Ltd., Illumina Inc., International Business Machines Corp., Mapmygenome India Ltd., myDNA Life Ltd., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Inc., Sysmex Corp., and Veritas Genetics Inc.

Few companies with key offerings

• 23andme.com - The company offers predictive presymptomatic testing such as BRCA1 and BRCA2 which helps in repairing DNA breaks that can lead to cancer.
• Abbott.com - The company offers predictive presymptomatic testing such as Vysis CEP 8 SpectrumOrange Direct Labeled Fluorescent DNA Probe Kit and Vysis CEP 12 SpectrumOrange Direct Labeled Fluorescent DNA Probe Kit.
• Color.com - The company offers predictive presymptomatic testing such as the Hereditary Cancer Test which helps reduce the risk of developing cancer.
• To know about the offerings of all major vendors - Download a free sample now!

Competitive Analysis

The report includes the competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Segmentation Analysis

• By Application, the market is classified as cancer diseases, genetic diseases, and cardiovascular diseases.
• By Geography, the market is classified as North America, Europe, Asia, and Rest of World (ROW).

To know about the contribution of each segment - Download a free sample now!

Related Reports 

• The feminine probiotic supplement market share is expected to increase by USD 565.77 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.51%. Download a free sample now!
• The porcine vaccine market share is expected to increase by USD 794.67 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.01%. Download a free sample now!

Table of Content

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

• 5.1 Market segments
• Exhibit 24: Chart on Application - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Application - Market share 2021-2026 (%)

• 5.2 Comparison by Application
• Exhibit 26: Chart on Comparison by Application
• Exhibit 27: Data Table on Comparison by Application

• 5.3 Cancer diseases - Market size and forecast 2021-2026
• Exhibit 28: Chart on Cancer diseases - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Cancer diseases - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Cancer diseases - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Cancer diseases - Year-over-year growth 2021-2026 (%)

• 5.4 Genetic diseases - Market size and forecast 2021-2026
• Exhibit 32: Chart on Genetic diseases - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Genetic diseases - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Genetic diseases - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Genetic diseases - Year-over-year growth 2021-2026 (%)

• 5.5 Cardiovascular diseases - Market size and forecast 2021-2026
• Exhibit 36: Chart on Cardiovascular diseases - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Cardiovascular diseases - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Cardiovascular diseases - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Cardiovascular diseases - Year-over-year growth 2021-2026 (%)

• 5.6 Market opportunity by Application
• Exhibit 40: Market opportunity by Application ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 42: Chart on Market share by geography 2021-2026 (%)
• Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 Japan - Market size and forecast 2021-2026
• Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.10 UK - Market size and forecast 2021-2026
• Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.11 France - Market size and forecast 2021-2026
• Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 88: Matrix on vendor position and classification

• 10.3 23andMe Inc.
• Exhibit 89: 23andMe Inc. - Overview
• Exhibit 90: 23andMe Inc. - Product / Service
• Exhibit 91: 23andMe Inc. - Key offerings

• 10.4 Abbott Laboratories
• Exhibit 92: Abbott Laboratories - Overview
• Exhibit 93: Abbott Laboratories - Business segments
• Exhibit 94: Abbott Laboratories - Key news
• Exhibit 95: Abbott Laboratories - Key offerings
• Exhibit 96: Abbott Laboratories - Segment focus

• 10.5 Color Genomics Inc.
• Exhibit 97: Color Genomics Inc. - Overview
• Exhibit 98: Color Genomics Inc. - Product / Service
• Exhibit 99: Color Genomics Inc. - Key offerings

• 10.6 Direct Laboratory Services LLC
• Exhibit 100: Direct Laboratory Services LLC - Overview
• Exhibit 101: Direct Laboratory Services LLC - Product / Service
• Exhibit 102: Direct Laboratory Services LLC - Key offerings

• 10.7 Healius Ltd.
• Exhibit 103: Healius Ltd. - Overview
• Exhibit 104: Healius Ltd. - Product / Service
• Exhibit 105: Healius Ltd. - Key offerings

• 10.8 Mapmygenome India Ltd.
• Exhibit 106: Mapmygenome India Ltd. - Overview
• Exhibit 107: Mapmygenome India Ltd. - Product / Service
• Exhibit 108: Mapmygenome India Ltd. - Key offerings

• 10.9 myDNA Life Ltd.
• Exhibit 109: myDNA Life Ltd. - Overview
• Exhibit 110: myDNA Life Ltd. - Product / Service
• Exhibit 111: myDNA Life Ltd. - Key offerings

• 10.10 Myriad Genetics Inc.
• Exhibit 112: Myriad Genetics Inc. - Overview
• Exhibit 113: Myriad Genetics Inc. - Business segments
• Exhibit 114: Myriad Genetics Inc. - Key offerings
• Exhibit 115: Myriad Genetics Inc. - Segment focus

• 10.11 Quest Diagnostics Inc.
• Exhibit 116: Quest Diagnostics Inc. - Overview
• Exhibit 117: Quest Diagnostics Inc. - Business segments
• Exhibit 118: Quest Diagnostics Inc. - Key offerings
• Exhibit 119: Quest Diagnostics Inc. - Segment focus

• 10.12 Sysmex Corp.
• Exhibit 120: Sysmex Corp. - Overview
• Exhibit 121: Sysmex Corp. - Business segments
• Exhibit 122: Sysmex Corp. - Key offerings
• Exhibit 123: Sysmex Corp. - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 124: Inclusions checklist
• Exhibit 125: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 126: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 127: Research methodology
• Exhibit 128: Validation techniques employed for market sizing
• Exhibit 129: Information sources

• 11.5 List of abbreviations
• Exhibit 130: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED